BHVN insider transactions

SEC Form 4 filed by Director Mehta Kishan

SEC Form 4 filed by Director Bailey Gregory

SEC Form 4 filed by Director Heffernan Michael Thomas

SEC Form 4 filed by Director Antonijevic Irina

SEC Form 4 filed by Director Childs John W

SEC Form 4 filed by Director Hugin Robert J

SEC Form 4 filed by Director Gregory Julia P

SEC Form 4 filed by Mehta Kishan

Amendment: Director Childs John W bought $864,115 worth of shares (28,400 units at $30.43) (SEC Form 4)

SEC Form 4 filed by Chief Financial Officer Buten Matthew

SEC Form 4 filed by SVP, Clinical Operations Gentile Kimberly

SEC Form 4 filed by VP, Chief Accounting Officer Clark George C.

SEC Form 4 filed by Chief Scientific Officer Car Bruce

SEC Form 4 filed by Chief Executive Officer Coric Vlad

SVP, Clinical Operations Gentile Kimberly covered exercise/tax liability with 1,956 shares and converted options into 3,750 shares, increasing direct ownership by 2% to 99,557 units (SEC Form 4)

Chief Financial Officer Buten Matthew converted options into 4,250 shares and covered exercise/tax liability with 2,594 shares, increasing direct ownership by 0.85% to 195,652 units (SEC Form 4)

Chief Executive Officer Coric Vlad converted options into 14,250 shares and covered exercise/tax liability with 7,430 shares, increasing direct ownership by 0.38% to 1,803,968 units (SEC Form 4)

Chief Scientific Officer Car Bruce converted options into 4,750 shares and covered exercise/tax liability with 2,381 shares, increasing direct ownership by 44% to 7,715 units (SEC Form 4)

VP, Chief Accounting Officer Clark George C. covered exercise/tax liability with 1,117 shares and converted options into 2,500 shares, increasing direct ownership by 2% to 66,978 units (SEC Form 4)

VP, Chief Accounting Officer Clark George C. bought $144,770 worth of shares (17,000 units at $8.52) (SEC Form 4)

Director Bailey Gregory bought $3,000,000 worth of shares (400,000 units at $7.50), increasing direct ownership by 25% to 2,020,071 units (SEC Form 4)

Director Childs John W bought $24,999,998 worth of shares (3,333,333 units at $7.50) (SEC Form 4)

Chief Executive Officer Coric Vlad bought $4,999,995 worth of shares (666,666 units at $7.50) (SEC Form 4)

SEC Form 4 filed by Director Antonijevic Irina

SEC Form 4 filed by Director Heffernan Michael Thomas

SEC Form 4 filed by Director Bailey Gregory

SEC Form 4 filed by Director Mehta Kishan

SEC Form 4 filed by Director Gregory Julia P

SEC Form 4 filed by Director Childs John W

SEC Form 4 filed by Director Hugin Robert J

Director Childs John W bought $996,238 worth of shares (32,700 units at $30.47) (SEC Form 4)

Amendment: Director Childs John W bought $2,999,970 worth of shares (73,170 units at $41.00) (SEC Form 4)

Chief Scientific Officer Car Bruce converted options into 4,750 shares and covered exercise/tax liability with 2,331 shares, increasing direct ownership by 102% to 4,802 units (SEC Form 4)

SVP, Clinical Operations Gentile Kimberly converted options into 3,750 shares and covered exercise/tax liability with 1,956 shares, increasing direct ownership by 2% to 97,763 units (SEC Form 4)

VP, Chief Accounting Officer Clark George C. converted options into 2,500 shares and covered exercise/tax liability with 1,117 shares, increasing direct ownership by 2% to 65,051 units (SEC Form 4)

Chief Financial Officer Buten Matthew converted options into 4,250 shares and covered exercise/tax liability with 2,561 shares, increasing direct ownership by 0.88% to 193,452 units (SEC Form 4)

Chief Executive Officer Coric Vlad converted options into 14,250 shares and covered exercise/tax liability with 6,805 shares, increasing direct ownership by 0.42% to 1,796,604 units (SEC Form 4)

Director Childs John W bought $1,042,393 worth of shares (29,000 units at $35.94) (SEC Form 4)

Director Childs John W bought $999,970 worth of shares (21,052 units at $47.50) (SEC Form 4)

Chief Executive Officer Coric Vlad bought $999,970 worth of shares (21,052 units at $47.50) (SEC Form 4)

Director Bailey Gregory bought $220,966 worth of shares (5,000 units at $44.19), increasing direct ownership by 0.31% to 1,620,071 units (SEC Form 4)

Director Childs John W bought $1,012,983 worth of shares (28,400 units at $35.67) (SEC Form 4)

Chief Scientific Officer Car Bruce bought $1,007,490 worth of shares (30,000 units at $33.58) (SEC Form 4)

Childs John W bought $996,240 worth of shares (28,000 units at $35.58) (SEC Form 4)

Bailey Gregory bought $512,877 worth of shares (15,000 units at $34.19), increasing direct ownership by 0.94% to 1,615,071 units (SEC Form 4)

Childs John W bought $1,002,470 worth of shares (28,500 units at $35.17) (SEC Form 4)

SEC Form 4 filed by Mehta Kishan

SEC Form 4 filed by Heffernan Michael Thomas

SEC Form 4 filed by Gregory Julia P

SEC Form 4 filed by Hugin Robert J

SEC Form 4 filed by Antonijevic Irina

SEC Form 4 filed by Childs John W

SEC Form 4 filed by Bailey Gregory

Bailey Gregory bought $999,169 worth of shares (25,503 units at $39.18), increasing direct ownership by 2% to 1,600,071 units (SEC Form 4)

Bailey Gregory bought $1,999,980 worth of shares (48,780 units at $41.00), increasing direct ownership by 3% to 1,574,568 units (SEC Form 4)

Childs John W bought $7,999,961 worth of shares (195,121 units at $41.00) (SEC Form 4)

Coric Vlad bought $4,999,991 worth of shares (121,951 units at $41.00), increasing direct ownership by 7% to 1,788,417 units (SEC Form 4)

Childs John W was granted 2,091 shares (SEC Form 4)

Coric Vlad was granted 694 shares, increasing direct ownership by 0.01% to 1,666,466 units (SEC Form 4)

Childs John W was granted 19,412 shares (SEC Form 4)